J B Chemicals & Pharmaceuticals Ltd
₹2053.50
(-1.34%)
Wed, 04 Mar 2026, 03:25 am
Health Technology
Pharmaceuticals: Major
24.5KJ B Chemicals & Pharmaceuticals Price to Sales Ratio (P/S)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 13.36 | 10.66 | 9.29 | 12.05 | 5.03 | 8.07 | 0.76 | 7.84 | 17.68 | 16.90 | 13.02 | 15.99 | 18.77 | 15.28 | 14.87 | 21.63 | 31.62 | 37.66 | 47.33 | 39.03 |
| Price to book ratio | 2.83 | 1.59 | 0.93 | 0.66 | 1.05 | 1.62 | 0.53 | 0.61 | 1.04 | 1.71 | 1.79 | 2.16 | 1.72 | 1.95 | 2.74 | 5.35 | 5.71 | 6.15 | 8.76 | 7.36 |
| Price to sales ratio | 2.12 | 1.28 | 0.74 | 0.46 | 0.82 | 1.29 | 0.67 | 0.74 | 1.09 | 1.51 | 1.81 | 2.24 | 1.87 | 1.84 | 2.33 | 4.84 | 5.07 | 4.93 | 7.54 | 6.61 |
| Price to cash flow ratio | 51.94 | 30.15 | 35.65 | 4 | 5.38 | 8.77 | 0.58 | 7.42 | 0 | 13.69 | 14.50 | 14.76 | 21.34 | 15.26 | 14.57 | 31.26 | 72.26 | 25.91 | 34.40 | 28.69 |
| Enterprise value | 10.22B | 8.17B | 6B | 4.42B | 6.53B | 11.64B | 671.47M | 1.24B | 6.67B | 12.48B | 20.5B | 27.56B | 22.15B | 25.87B | 37.18B | 90.41B | 121.85B | 157.35B | 260.75B | 253.18B |
| Enterprise value to EBITDA ratio | 11.90 | 10.86 | 8.92 | 5.24 | 4.74 | 6.65 | 0.64 | 1.31 | 5.01 | 6.86 | 9.49 | 13.23 | 10.82 | 9.30 | 10.41 | 17.24 | 22.86 | 22.51 | 29.19 | 24.89 |
| Debt to equity ratio | 0.29 | 0.42 | 0.43 | 0.38 | 0.23 | 0.24 | 0.07 | 0.05 | 0.09 | 0.13 | 0.16 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.23 | 0.13 | 0.01 |
| Return on equity % | 22.86 | 16.61 | 10.40 | 5.58 | 22.90 | 22.12 | 81.65 | 7.99 | 5.97 | 9.86 | 14.93 | 14.45 | 9.87 | 13.25 | 18.67 | 27.61 | 19.55 | 17.77 | 20.46 | 20.75 |
J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio
The J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate J B Chemicals & Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
J B Chemicals & Pharmaceuticals Ltd (NSE: JBCHEPHARM, BSE: 506943) is currently trading at ₹2053.50, with a market capitalization of ₹329.61B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio is essential for fundamental analysis.
J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio Current Value
The current J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio stands at 6.61.
The J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio Historical Trend
The J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 6.61
- 2023: 7.54
- 2022: 4.93
- 2021: 5.07
- 2020: 4.84
The decline in J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.
What J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio Indicates for Investors
The J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio Analysis Summary
The J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of J B Chemicals & Pharmaceuticals Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800